日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncologists' preferences for first-line treatment of ALK-positive metastatic NSCLC in the United States: a discrete choice experiment

美国肿瘤科医生对ALK阳性转移性非小细胞肺癌一线治疗方案的偏好:一项离散选择实验

Mileham, Kathryn F; Panattoni, Laura; Gahlon, Grace; Labisa, Pedro; Bariahtaris, Nicole; Graf, Marlon; Danes, Christopher; Hernandez, Luis

IASLC grading system predicts distant metastases for resected lung adenocarcinoma

IASLC分级系统可预测切除肺腺癌的远处转移

Wang, Yuezhu; Smith, Margaret R; Dixon, Caroline B; D'Agostino, Ralph; Liu, Yin; Ruiz, Jimmy; Chan, Michael D; Su, Jing; Mileham, Kathryn F; Lycan, Thomas; Green, Mary E; Hassan, Omer A; Jiang, Yuming; Khan Niazi, M Khalid; Li, Wencheng; Xing, Fei

Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer

靶向 NTRK1 可增强免疫检查点抑制剂在 NTRK1 野生型非小细胞肺癌中的疗效

Margaret R Smith ,Caroline B Dixon ,Yuezhu Wang ,Yin Liu ,Ralph D'Agostino Jr ,Jimmy Ruiz ,George Oliver ,Lance D Miller ,Umit Topaloglu ,Michael D Chan ,Michael Farris ,Jing Su ,Kathryn F Mileham ,Dawen Zhao ,Wencheng Li ,Tammy Sexton ,Thomas Lycan ,Karen M Haas ,Jason M Grayson ,Fei Xing

Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies

接受免疫治疗的非小细胞肺癌患者中与高级别免疫相关不良事件相关的突变

Smith, Margaret R; Wang, Yuezhu; Dixon, Caroline B; D'Agostino, Ralph; Liu, Yin; Ruiz, Jimmy; Oliver, George; Miller, Lance D; Topaloglu, Umit; Chan, Michael D; Farris, Michael; Su, Jing; Mileham, Kathryn F; Li, Wencheng; Grayson, Jason M; Lycan, Thomas; Xing, Fei

Phosphodiesterase Inhibition to Sensitize Non-Small-Cell Lung Cancer to Pemetrexed: A Double-Edged Strategy

磷酸二酯酶抑制剂增强非小细胞肺癌对培美曲塞的敏感性:双刃剑策略

Anna V Ivanina Foureau, David M Foureau, Cody C McHale, Fei Guo, Carol J Farhangfar, Kathryn F Mileham

Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont Study

抗叶酸反应特征状态与培美曲塞-铂类化疗在非小细胞肺癌中的临床活性之间的关联:皮埃蒙特研究

Eisner, Joel R; Mayhew, Gregory M; Davison, James M; Beebe, Kirk D; Shibata, Yoichiro; Guo, Yuelong; Farhangfar, Carol; Farhangfar, Farhang; Uronis, Joshua M; Conroy, Jeffrey M; Milburn, Michael V; Hayes, David Neil; Mileham, Kathryn F

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy

接受化疗、免疫疗法和化疗联合免疫疗法治疗的非小细胞肺癌患者的预后突变特征

Smith, Margaret R; Wang, Yuezhu; D'Agostino, Ralph Jr; Liu, Yin; Ruiz, Jimmy; Lycan, Thomas; Oliver, George; Miller, Lance D; Topaloglu, Umit; Pinkney, Jireh; Abdulhaleem, Mohammed N; Chan, Michael D; Farris, Michael; Su, Jing; Mileham, Kathryn F; Xing, Fei

Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report

劳拉替尼在ALK或ROS1重排晚期非小细胞肺癌患者中的耐受性及其与临床结局的关系:简要报告

Thummalapalli, Rohit; Choudhury, Noura J; Ehrich, Fiona; Beardslee, Tyler; Brazel, Danielle; Zhang, Shannon S; Merchant, Shelby; Chen, Monica F; Heller, Glenn; Ramalingam, Suresh S; Ou, Sai-Hong Ignatius; Mileham, Kathryn F; Riely, Gregory J

Landscape and clinical impact of metabolic alterations in non-squamous non-small cell lung cancer

非鳞状非小细胞肺癌代谢改变的现状及临床影响

Ivanina Foureau, Anna V; Sha, Wei; Foureau, David M; Symanowski, James T; Farhangfar, Carol J; Mileham, Kathryn F

Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists

制定晚期非小细胞肺癌的综合生物标志物相关检测和治疗方案:一项针对美国肿瘤科医生的调查结果

Mileham, Kathryn F; Schenkel, Caroline; Bruinooge, Suanna S; Freeman-Daily, Janet; Basu Roy, Upal; Moore, Amy; Smith, Robert A; Garrett-Mayer, Elizabeth; Rosenthal, Lauren; Garon, Edward B; Johnson, Bruce E; Osarogiagbon, Raymond U; Jalal, Shadia; Virani, Shamsuddin; Weber Redman, Mary; Silvestri, Gerard A